Evidence map›Paper›PMID 41048726›Full record

ReviewACS omega2025

Aminic Organoselenium Compounds: Promising Antioxidant Agents.

Babli Chhillar, João M Brito, Nikhil Sodhi, Climei R Cabreira, Sumbal Saba, Jamal Rafique, Vijay P Singh

Abstract readReview
In one paragraph

Review in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Babli ChhillarDepartment of Chemistry & Centre of Advanced Studies in Chemistry, Panjab University, Sector-14, Chandigarh 160 014, India.
João M BritoLabSO, Instituto de Química-IQ, Universidade Federal de Goiás-UFG, Goiânia 74690-900, GO, Brazil.
Nikhil SodhiDepartment of Chemistry & Centre of Advanced Studies in Chemistry, Panjab University, Sector-14, Chandigarh 160 014, India.
Climei R CabreiraInstituto de Química-INQUI, Universidade Federal do Mato Grosso do Sul-UFMS, Campo Grande 79074-460, MS, Brazil.
Sumbal SabaLabSO, Instituto de Química-IQ, Universidade Federal de Goiás-UFG, Goiânia 74690-900, GO, Brazil.ORCID https://orcid.org/0000-0002-6134-7249
Jamal RafiqueLabSO, Instituto de Química-IQ, Universidade Federal de Goiás-UFG, Goiânia 74690-900, GO, Brazil.ORCID https://orcid.org/0000-0002-2336-040X
Vijay P SinghDepartment of Chemistry & Centre of Advanced Studies in Chemistry, Panjab University, Sector-14, Chandigarh 160 014, India.ORCID https://orcid.org/0000-0002-5584-2067

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significant research interest has been devoted to organoselenium compounds due to their diverse biological activities, particularly their antioxidant properties, which mimic those of glutathione peroxidase (GPx) enzymes. While previous reviews have explored the broad spectrum of organoselenium chemistry and their applications, this review focuses specifically on aminic organoselenium compounds as next-generation GPx mimics and radical-trapping antioxidants. This work presents a comprehensive analysis of their catalytic mechanisms and structure-activity relationships (SAR) and the methodologies employed to evaluate their antioxidant efficacy. Unlike earlier reviews, this work emphasizes the critical role of aminic moieties in enhancing GPx-like activity and dual functionalities (peroxide decomposition and radical quenching). Key topics include the design principles of aminic organoselenium compounds, their performance relative to classical antioxidants like ebselen and α-tocopherol, and their promising use in developing treatments for conditions linked to oxidative stress. By consolidating advancements from the past two decades, this review connects existing research areas and suggests valuable pathways for future studies in developing multifunctional organoselenium antioxidants.

Identifiers

PMID41048726
PMCPMC12489635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.